How do you make the most of your health discoveries? Therapeutic Innovation Australia believes that collaboration is key to meeting the challenges of research commercialisation. To help bring together Australia’s therapeutic sector, this year they launched a new collaborative, the Australian Therapeutic Pipeline. This will support Australian researchers in their drive to translate their discoveries from research into clinical application.
We look forward to seeing more new biopharmaceuticals, cell therapies, diagnostics, and personalised medicines launch from Australia to the world under this initiative.

By Emma Armitage, Business Analyst, BioPacific Partners

When you’re passionate about biotech you’ve got to keep your ear to the ground for new developments. What better way to do that then by attending Australia and Asia-Pacific’s largest annual gathering of biotechnology experts?

The AusBiotech national conference kicks off today with the theme ‘Life Science = Future. Jobs. Exports.’ In attendance from BioPacific Partners are Executive Directors Andrew Kelly and Margot Bethell, and Investment Manager Sujit Kalidas.

We’re looking forward to a great few days of meeting with international biotech leaders and scoping out new industry innovation. The thought-provoking conference program includes sessions on translating discoveries out of the lab, ‘investors unplugged’, and personalised medicine. On top of this, the highlight for us will be the networking that occurs both outside and inside the conference. Within the conference, AusBiotech’s Business Matching Program connects participants from the biotechnology, biopharmaceutical, life sciences, business, investment, research and health industries.

If you are attending the conference, you can set up meetings with our team either through the business matching portal, or by looking out for us around the event. Couldn’t make it to the conference? Contact us to set up a meeting.


At BioPacific we know that understanding our region’s innovation ecosystem is core to our business.  So not only do we work with it, we also study it to try to make it better.  We recently published two papers about the venture capital ecosystem based on work by Sujit Kalidas during his internship with BioPacific and the University of Auckland.  For obvious reasons, Sujit is now a valued employee!

Continue Reading…

Innovators and angels

Last week saw the advent of two of New Zealand’s biggest tech innovation events – the New Zealand Angel Investment Showcase and the NZ Innovators Awards. Networks were made, ideas were pitched, innovations were celebrated, and a great night of cheer and wine was had by all.

The Angel Showcase gave 14 emerging kiwi companies a chance to pitch to a record crowd, including many high net worth investors. Our Executive Director, Dr Andrew Kelly, described this year’s event as “the best set of innovation pitches this country has seen, and it showcased the best of innovations from this region.” 

Continue Reading…

Innovation is increasingly recognised as essential to developing a dynamic and successful business. However, despite achievements in corporate R&D labs, it’s not always easy for large companies to remain nimble and innovative as they grow. VC backed start-up companies are a great alternative source of entrepreneurial inventions, although the 10-year exit timeframe can limit options in the life sciences industry, which typically takes a longer time to pay off.

Continue Reading…

New Zealand dairy co-operative Tatua has reported an annual 27% increase in earnings – a personal best per kg of milksolids for Tatua, and likely a record for the industry.

In a discussion with APNZ, chief executive Paul McGilvary noted that “the key difference with Tatua is that we don’t make milk powder at all, and we don’t make butter or cheese.” For a dairy company this may sound strange, but as McGilvary explains, “a relatively high proportion of the business … is in value added.” Indeed, Tatua’s strengths lie in high value speciality areas such as ingredients, flavours, and nutrition products.

This is a great example of a smart New Zealand business enhancing their strategy through innovation. It speaks to the advantage that adding value and taking calculated risks can generate.

By Emma Armitage, Business Analyst, BioPacific Partners

Robots rising up on NZ farms

Agriculture and robotics are developing in tandem in New Zealand with the help of Callaghan Innovation. Robotics researchers at this leading science research institute are developing specialist sensor technology for pasture care, monitoring, and crop harvesting.

In the future, the collation of data from sensor systems such as these will allow identification of patterns, helping farms and businesses increase their efficiency, optimise crop yields, and reduce waste.

By Emma Armitage, Business Analyst, BioPacific Partners

Singapore research trip

One of our team members, Emma Armitage, is completing a Masters thesis on life science innovation in SE Asia. As part of this, she recently completed a trip to Singapore, where she interviewed key industry professionals about resources for start-ups and the innovation ecosystem in Singapore. Keep an eye on our news page for more updates as her project progresses.